TetraGraph in Rocuronium Infusions

Joseph D. Tobias

Status: Active, not recruiting

Conditions: Surgery

Treatments: Device: TetraGraph

Study type: Interventional

Funder types: Other

Identifiers

NCT06472284

STUDY00004154

Details and patient eligibility

About

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Enrollment: 50 patients

Sex: All

Ages: 28 days to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients less than 18 years of age
• American Society of Anesthesiologists classification (ASA) 1-4
• Patients undergoing a surgical procedure with general anesthesia and requiring the continuous administration of rocuroniuim

Exclusion criteria

• Patients less than 28 days old
• Patients with history of a progressive or degenerative peripheral neurologic or neuropathic disorder
• Patients undergoing a surgical procedure in which neuromuscular blockade is not required
• Edematous patients

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Rocuronium infusion

Experimental group

Description:

Patients who are scheduled for elective, urgent or emergent surgery requiring the continuous infusion of the neuromuscular blocking agent, rocuronium.

Treatment:

Device: TetraGraph